Related Experiment Video
Updated: May 19, 2026

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Telerheumatology: an idea whose time has come
L J Roberts1, E G Lamont, I Lim
1School of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia. lynden.roberts@JCU.edu.au
Internal Medicine Journal
|August 31, 2012
Summary
Telehealth can improve access to rheumatologists for Australians outside major cities, reducing disability from rheumatic diseases. A mixed model of in-person and virtual care offers the best solution for remote patient management.
Area of Science:
- Rheumatology
- Digital Health
- Health Services Research
Background:
- One-third of Australians live outside capital cities, facing challenges accessing specialist rheumatologist care.
- Rheumatic diseases like rheumatoid arthritis require timely, complex treatment to prevent joint damage and disability.
- Limited access to rheumatologists for non-metropolitan Australians contributes to preventable disability.
Purpose of the Study:
- To review the evidence for telehealth in managing rheumatic diseases in Australia.
- To outline the strengths and weaknesses of telehealth for rheumatology.
- To discuss technological, medicolegal, and financial considerations for telehealth implementation.
Main Methods:
- Literature review of current evidence on telehealth in rheumatology.
- Analysis of technological advancements and government incentives.
- Discussion of practical aspects of implementing telehealth models.
Main Results:
- Telehealth offers potential to improve specialist access for rural and remote patients.
- Key challenges include technological, medicolegal, and financial barriers.
- A mixed model combining face-to-face and virtual consultations is proposed.
Conclusions:
- Telehealth can significantly enhance access to rheumatology care for underserved populations.
- Addressing implementation barriers is crucial for successful telehealth adoption.
- A hybrid care model balances accessibility with the need for in-person assessment.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
